US4593002A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Viruses with recombinant surface proteins
Assignee: Merck and Co Inc
•
Filing: 1982-01-11
•
Granted: 1986-06-03
•
Expires: 2002-01-11
Abstract
Abstract Foreign protein segments having specific medically or commercially useful biological functions are incorporated in surface proteins of viruses. The viruses with the incorporated protein segments are convenient agents for introducing the protein segments into animals, such as humans, and are thus useful as vaccines. Small segments of an original protein exhibiting desired functions are identified, and a DNA fragment having a nucleotide base sequence encoding that segment of the protein is isolated from an organism or synthesized chemically. The isolated DNA fragment is inserted into the DNA genome of a virus in a manner such that the inserted DNA fragment expresses itself as the foreign segment of a surface viral protein and in such a way that neither the function of the protein segment nor the function of any viral protein critical for viral replication is impaired.
Inventors
- 👤 Renato Dulbecco
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:24
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/86; A; A61; A61K; A61K39/00; C12N2710/00; C12N2710/00011; C12N2710/10011; C12N2710/10311; C12N2710/10322; C12N2760/00; C12N2760/00011; C12N2760/20011; C12N2760/20211; C12N2760/20222; C12N2770/00; C12N2770/00011; C12N2770/32011; C12N2770/32611; C12N2770/32622; C12N2795/00; C12N2795/00011; C12N2795/10011; C12N2795/10311; C12N2795/10341; C12N2795/10343; Y; Y02; Y02A; Y02A50/00; Y02A50/30
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
59 words
A method of modifying a virus to give the virus a new biological function comprising inserting a foreign nucleotide base sequence into the viral genome at a location whereat said foreign nucleotide base sequence expresses itself as an exposed segment of a surface viral protein, which surface viral protein forms a part of the coat of the modified virus.
Claim 2
Independent Claim
59 words
A method of modifying a virus to give the virus a new biological function comprising inserting a foreign nucleotide base sequence into the viral genome at a location whereat said foreign nucleotide base sequence expresses itself as an exposed segment of a surface viral protein, which surface viral protein forms a part of the coat of the modified virus.
Claim 3
Dependent Claim
104 words
A method according to claim 1 further comprising examining the known molecular biology of said virus and choosing a surface viral protein which, according to its molecular biology, is not critical to the reproductive viability of said virus or a portion of a surface protein which, according to the molecular biology of said virus, is not critical to the reproductive viability of said virus, and inserting said foreign nucleotide base sequence into the viral genome at a location whereat said foreign nucleotide base sequence is expressed as an exposed segment of said noncritical surface protein or of said noncritical portion of a surface protein.
Claim 4
Dependent Claim
125 words
A method according to claim 1 wherein said foreign nucleotide base sequence is inserted into said genome by splicing into a cloning vector a portion of said viral genome containing at least a fragment of the gene for said surface protein, infecting an organism with said spliced cloning vector to obtain multiple copies of said spliced cloning vector, cleaving said spliced cloning vector at a location within said surface protein gene fragment, linking said foreign nucleotide base sequence to the cleaved ends of said surface protein gene fragment, isolating said spliced portion of said viral genome portion containing said foreign nucleotide base sequence, from said cloning vector, and joining said isolated genome portion with additional viral genome portions necessary to create a functional viral genome.
Claim 5
Dependent Claim
22 words
A method according to claim 3 further comprising packaging said viral genome, containing said foreign nucleotide base sequence, as a complete virus.
Claim 6
Independent Claim
91 words
A method of modifying a virus to produce a modified virus for introduction into a live animal comprising selecting for modification a virus which is known to be non-pathogenic in the animal into which said modified virus is to be introduced, and inserting a foreign nucleotide base sequence into the viral genome of said selected virus at a location whereat said foreign nucleotide base sequence is expressed as an exposed segment of a surface viral protein, which expressed surface viral protein forms a part of the coat of the modified virus.
Claim 7
Independent Claim
91 words
A method of modifying a virus to produce a modified virus for introduction into a live animal comprising selecting for modification a virus which is known to be non-pathogenic in the animal into which said modified virus is to be introduced, and inserting a foreign nucleotide base sequence into the viral genome of said selected virus at a location whereat said foreign nucleotide base sequence is expressed as an exposed segment of a surface viral protein, which expressed surface viral protein forms a part of the coat of the modified virus.
Claim 8
Independent Claim
85 words
A method of producing an agent which induces an immunological response in an animal comprising choosing a known immune-response-inducing segment of a protein, isolating a nucleotide base sequence which codes for said protein segment, inserting said isolated nucleotide base sequence into the genome of a virus at a location whereat said nucleotide base sequence is expressed as an exposed segment of a viral surface protein without disrupting reproductive viability of said virus which surface viral protein forms a part of the coat of the virus.
Claim 9
Independent Claim
85 words
A method of producing an agent which induces an immunological response in an animal comprising choosing a known immune-response-inducing segment of a protein, isolating a nucleotide base sequence which codes for said protein segment, inserting said isolated nucleotide base sequence into the genome of a virus at a location whereat said nucleotide base sequence is expressed as an exposed segment of a viral surface protein without disrupting reproductive viability of said virus which surface viral protein forms a part of the coat of the virus.
Claim 10
Dependent Claim
37 words
A method of producing an agent according to claim 6 wherein a nucleotide base sequence is inserted into the genome of a virus that is non-pathogenic to an animal, whereby said agent is useful as a vaccine.
Claim 11
Independent Claim
257 words
A method of producing a modified virus which carries an exposed segment of a foreign protein, which segment is known to be immunologically active within an animal into which the modified virus is to be introduced, the method comprising selecting a virus for modification which is non-pathogenic in the animal, examining the known molecular biology of said selected virus and choosing a surface protein of said virus which, according to its molecular biology, is not critical to the reproductive viability of said virus or a portion of a surface protein which, according to the molecular biology of said virus, is not critical to the reproductive viabliity of said virus, splicing into a cloning vector a portion of the genome of said virus which contains at least a fragment of the gene that encodes said surface protein, transforming a microorganism with said spliced cloning vector to obtain multiple copies of said spliced cloning vector, choosing a known immune-response-inducing segment of a protein that is foreign to said virus, isolating a nucleotide base sequence which encodes said foreign protein segment, cleaving said spliced cloning vector at a location within said surface protein-encoding genome portion, linking said foreign nucleotide base sequence to the cleaved ends of said surface protein-encoding genome portion, isolating said linked viral genome portion containing said foreign nucleotide base sequence from said cloning vector, joining said isolated genome portion to additional viral genome portions necessary to create a functional viral genome, and packaging said functional viral genome, containing said foreign nucleotide base sequence, as a complete virus.
Claim 12
Independent Claim
257 words
A method of producing a modified virus which carries an exposed segment of a foreign protein, which segment is known to be immunologically active within an animal into which the modified virus is to be introduced, the method comprising selecting a virus for modification which is non-pathogenic in the animal, examining the known molecular biology of said selected virus and choosing a surface protein of said virus which, according to its molecular biology, is not critical to the reproductive viability of said virus or a portion of a surface protein which, according to the molecular biology of said virus, is not critical to the reproductive viabliity of said virus, splicing into a cloning vector a portion of the genome of said virus which contains at least a fragment of the gene that encodes said surface protein, transforming a microorganism with said spliced cloning vector to obtain multiple copies of said spliced cloning vector, choosing a known immune-response-inducing segment of a protein that is foreign to said virus, isolating a nucleotide base sequence which encodes said foreign protein segment, cleaving said spliced cloning vector at a location within said surface protein-encoding genome portion, linking said foreign nucleotide base sequence to the cleaved ends of said surface protein-encoding genome portion, isolating said linked viral genome portion containing said foreign nucleotide base sequence from said cloning vector, joining said isolated genome portion to additional viral genome portions necessary to create a functional viral genome, and packaging said functional viral genome, containing said foreign nucleotide base sequence, as a complete virus.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-06-02 | 1989-12-02 | 1990-06-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-06-02 | 1993-12-02 | 1994-06-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-06-02 | 1997-12-02 | 1998-06-03 | $7700.00 | Window Closed / Lapsed |